학술논문
Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial.
Document Type
Article
Author
Sawano, Fumio; Kamei, Nozomu; Miyahara, Mitsue; Kobuke, Kyoko; Nakanishi, Shuhei; Nagano, Chihiro; Nojima, Hideki; Maeda, Shusaku; Watanabe, Hiroshi; Kishimoto, Rui; Yamashita, Mami; Hamaoka, Aya; Mukai, Kana; Tsuboi, Tomoko; Mochizuki, Hisayoshi; Nakashima, Reiko; Sakashita, Yu; Morishita, Hisaaki; Kitamura, Tadahiro
Source
Diabetology International; Oct2021, Vol. 12 Issue 4, p364-378, 15p
Subject
Language
ISSN
21901678
Abstract
Copyright of Diabetology International is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)